Pfizer 2026 Hemophilia Fellowship

A competitive fellowship program supporting institution-based training that emphasizes shared decision making, patient education, and multidisciplinary team-based care to strengthen hemophilia care through equitable education in a rapidly evolving treatment landscape. 

Overview

• Grant funding up to $100,000 USD to support one fellow for one year 
• Budget can only include fellow salary and benefits - no overhead or indirect costs 
• Funding awarded to institution, not individual fellow 
• Fellow must complete capstone project with structured education program including care for underserved populations and SDM training curriculum 
• Strong mentoring program and independent research opportunities provided by institution 
• Program starts August 2027 or earlier with anticipated end date of August 2028 or earlier 

Priority Areas

• Shared decision making (SDM) and patient education: Strengthening hemophilia care through equitable education and patient-centered shared decision making
• Underserved populations: Addressing educational needs, barriers and gaps for People Living with Hemophilia (PLwH) relating to new treatment landscape
• Workforce development: Supporting clinical training, particularly in regions facing ongoing workforce challenges
• Independent research: Observational studies and outcomes research focused on scientific understanding of disease; use of screening tools and their impact on improvement of patient health 
• Interdisciplinary team-based care: Educational time with interdisciplinary team in review of case examples and relevant didactic training 

Eligibility & Requirements

Institutional Eligibility:

• Accredited, US-based academic institution
• Institution must have fellowship programs that include independent research and strong mentoring program 
• Institution should demonstrate robust commitment to clinical practice, research, and education, advancing knowledge in hemophilia
• Clinical training may be included but is not required 
• Do not include name of potential fellow(s) in application materials - grant awarded to institution, not individual 

Fellow Requirements:

• Fellow must be U.S. Worker (U.S. citizen, permanent resident, refugee, or asylee) or hold appropriate non-immigrant visa status authorizing employment in U.S. 
• Fellow will be named in transparency reporting as recipient of grant funding per U.S. Physician Payments Sunshine Act requirements 
• Fellow time spent in clinical setting supported through grant funds must not be billed as patient care 

Program Restrictions:

• No aspect of fellowship program can benefit Pfizer's business or a Pfizer asset 
• Research involving study/evaluation of any pharmaceutical product is not eligible 
• Basic science and/or fundamental research (animal model, in-vitro, etc.) is not eligible 

Evaluation Criteria:

• Proposals evaluated based on: fellowship goals, objectives, medical needs and population health, patient care experience, program criteria, mentoring, training opportunities, and resources 
•  Expert review panel (ERP) comprised of professionals from medical community with advanced degrees and expertise in clinical areas

Timeline

• 01 April 2026: RFP Release Date 
• 28 May 2026 (23:59 EST): Submission Deadline - applications submitted after due date will not be reviewed
• 17 July 2026: Anticipated Grant Award Notification
• August 2027 or earlier: Anticipated Project Start Date 
• August 2028 or earlier: Anticipated Project End Date
• All applicants notified via email; applicants may be asked for additional clarification during review period

How to Submit:

• Access the application portal and sign in 
• First-time users should click "Create your password" 
• Click "Start A New Fellowship Application" button
• Complete all required sections of online application
• Upload proposal using required Proposal Template (10-15 pages, single-spaced, 12-point font, 1-inch margins) 
• In application, select "Yes" for "Competitive Grant?" question 
• Select Primary Area of Interest: "Genetics - Hemophilia - FEL" 
• Select Competitive Grant Program Name: "2026 RD US Hemophilia Fellowship" 
   

Please note: Full RFP is attached in the "More Information" section of this page. Faculty and researchers interested in applying for these opportunities based on technologies developed or disclosed at Vanderbilt must submit their proposals through the CTTC.